Date: 21 Nov 2012
Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
In previous studies, we observed a positive association between Trichomonas vaginalis serostatus and risk of prostate cancer, particularly aggressive cancer, which we hypothesized might be due to T. vaginalis-mediated intraprostatic inflammation and cell damage. To explore this hypothesis further, we investigated effect modification by Toll-like receptor 4 (TLR4) variation on this association. We hypothesized that TLR4 variation might serve a marker of the anti-trichomonad immune response because T. vaginalis has been shown to elicit inflammation through this receptor.
We previously genotyped the non-synonymous TLR4 single nucleotide polymorphism (SNP), rs4986790, and determined T. vaginalis serostatus for 690 incident prostate cancer cases and 692 controls in a nested case–control study within the Health Professionals Follow-up Study.
A non-significant suggestion of effect modification was observed by rs4986790 carrier status on the association between T. vaginalis serostatus and prostate cancer risk (p interaction = 0.07). While no association was observed among men homozygous wildtype for this SNP (odds ratio (OR) = 1.23, 95 % confidence interval (CI): 0.86–1.77), a positive association was observed among variant carriers (OR = 4.16, 95 % CI: 1.32–13.1).
Although not statistically significant, TLR4 variation appeared to influence the association between T. vaginalis serostatus and prostate cancer risk consistent with the hypothesis that inflammation plays a role in this association. Larger studies will be necessary to explore this possible effect modification further.
Information contained in this manuscript was presented as an abstract at the American Association for Cancer Research Annual meeting in Washington, DC, in April, 2010.
Yen-Ching Chen and Yi-Ling Huang contributed equally to this work.
Holmes KK, Sparling PF, Stamm WE et al (eds) (2008) Sexually transmitted diseases, 4th edn. McGraw-Hill Medical, New York
Gardner WA Jr, Culberson DE, Bennett BD (1986) Trichomonas vaginalis in the prostate gland. Arch Pathol Lab Med 110(5):430–432PubMed
Smith CJ, Gardner WA Jr (1987) Inflammation-proliferation: possible relationships in the prostate. In: Coffey DS, Bruchovsky N, Gardner WA, Resnick MI, Karr JP (eds) Current concepts and approaches to the study of prostate cancer. Alan R. Liss, Inc., New York, pp 317–25
Schroder NW, Schumann RR (2005) Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 5(3):156–164PubMed
den Dekker WK, Cheng C, Pasterkamp G, Duckers HJ (2010) Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis 209(2):314–320CrossRef
Khoshnan A, Alderete JF (1995) Characterization of double-stranded RNA satellites associated with the Trichomonas vaginalis virus. J Virol 69(11):6892–6897PubMed
Alderete JF (1999) Iron modulates phenotypic variation and phosphorylation of P270 in double-stranded RNA virus-infected Trichomonas vaginalis. Infect Immun 67(8):4298–4302PubMed
Provenzano D, Alderete JF (1995) Analysis of human immunoglobulin-degrading cysteine proteinases of Trichomonas vaginalis. Infect Immun 63(9):3388–3395PubMed
Alderete JF, Newton E, Dennis C, Neale KA (1991) The vagina of women infected with Trichomonas vaginalis has numerous proteinases and antibody to trichomonad proteinases. Genitourin Med 67(6):469–474PubMed
Shui IM, Stark JR, Penney KL et al (2012) Genetic variation in the toll-like receptor 4 and prostate cancer incidence and mortality. Prostate 72(2):209–216
- Prospective study of effect modification by Toll-like receptor 4 variation on the association between Trichomonas vaginalis serostatus and prostate cancer
Cancer Causes & Control
Volume 24, Issue 1 , pp 175-180
- Cover Date
- Print ISSN
- Online ISSN
- Springer Netherlands
- Additional Links
- Toll-like receptor 4
- T. vaginalis
- Prostate cancer
- Industry Sectors
- Author Affiliations
- 1. Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan
- 2. Research Center for Gene, Environment, and Human Health, National Taiwan University, Taipei, Taiwan
- 3. Department of Public Health, College of Public Health, National Taiwan University, Taipei, Taiwan
- 4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
- 5. School of Molecular Biosciences, Washington State University, Pullman, WA, USA
- 6. Department of Biostatistics, Harvard School of Public Health, Boston, MA, USA
- 7. Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
- 8. Channing Laboratory, Department of Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA
- 9. Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
- 10. Division of Public Health Sciences, Department of Surgery, Alvin J. Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA